Navigation Links
CHPA Statement on Statewide Indiana Consumer Poll
Date:3/4/2013

WASHINGTON, March 4, 2013 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) released the following statement today on a recent poll of Indiana voters conducted by The Polling Company and supported by CHPA. The poll, which surveyed 607 Hoosiers on February 4-6th, found that a 65 percent majority of Hoosiers opposed changing state law to require a doctor's prescription for cold and allergy medicines containing the decongestant pseudoephedrine (PSE).  The poll also found that 84 percent of respondents report they use PSE-containing medicines to treat common symptoms.

"The new Indiana survey is very important because in recent months, well-intentioned lawmakers have proposed legislation that would make it difficult for law-abiding Hoosiers to access the nonprescription medicines they know and trust," said Carlos Gutierrez , senior director of state government affairs for CHPA. "Clearly these proposals do not have the support of Indiana voters, many of whom sufferer from frequent cold and allergy symptoms. While we support efforts to combat the illegal sales of pseudoephedrine, lawmakers should advance solutions that target criminals, not honest citizens. To that end, CHPA is doing everything possible to help Senator Carlin Yoder garner support for his commonsense anti-meth bill, SB 496. Senator Yoder's bill would enhance the state's electronic PSE tracking system, implement stiffer penalties for meth-related crime, and apply sensible PSE purchasing limits."

Key findings from the poll:  

  • 84% of Hoosiers report they rely on the over-the-counter medicines containing pseudoephedrine that would be impacted by changing the law to require a doctor's prescription.
  • A 65%-majority of Hoosiers opposed changing the law to require a doctor's prescription for the purchase of cold and allergy medicines containing pseudoephedrine.  This total included 52% that STRONGLY opposed new rules for pseudoephedrine medicines that are currently sold over-the-counter.  In contrast, 29% of voters supported the new law.
  • By a 59%-35% spread, voters were more likely to agree "it is not worth inconveniencing, or possibly criminalizing law-abiding Hoosiers who benefit from over-the-counter cold or allergy medicines" than that "the benefits would outweigh the inconvenience or cost of a new law."
  • A 65%-majority were "less supportive" toward changing the law knowing that it could increase costs to taxpayers, as uninsured Hoosiers would have to visit emergency rooms to get prescriptions for these medicines.

CHPA is the 132-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and dietary supplements.

chpa-info.org


'/>"/>
SOURCE Consumer Healthcare Products Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sonitus Medical Announces Affirmative Update Regarding Bone Conduction Oral Appliances in American Academy of Otolaryngology-Head and Neck Surgery Policy Statement on Implantable Hearing Devices
2. Amgen Statement On Government Budget Analysis For Oral-Only Treatments For Dialysis Patients
3. Statement from Ralph G. Neas, President and CEO, Generic Pharmaceutical Association, on the Front Page New York Times Story Regarding the Pre-emptive Strikes of Amgen/Genentech to Restrict Access to Affordable and Safe Biosimilars
4. Emmaus Life Sciences Issues Statement in Response to Announcement by AFH Holding & Advisory
5. Hill-Rom Reports Fiscal First Quarter Results; Updates 2013 Financial Outlook For R&D Tax Credit Reinstatement
6. CVS Caremark Statement and Response to CMS Action
7. World Renowned Scientist, Dr. Rongxiang Xu Speaks Out About Nobel Assembly Statement Claiming They Have Not Heard Of Him
8. STATEMENT OF CHAIRMAN AND CEO GEORGE BARRETT FORTUNE 21 CARDINAL HEALTH REGARDING FISCAL CLIFF
9. PCMA Statement on Essential Health Benefits Proposed Rule
10. Emmaus CEO Yutaka Niihara, M.D., Issues Statement In Connection with Status of Companys Phase III FDA Sickle Cell Treatment Trials
11. Academy of Managed Care Pharmacy (AMCP) Statement on Outcome of 2012 Presidential Election
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... February 12, 2016 ... titled Chronic Inflammation Global Clinical Trials Review, H2, ... the global clinical trials landscape along with top ... Region, Country (G7 & E7), Trial Status, Trial ... reviews top companies involved and enlists all trials ...
(Date:2/11/2016)... Feb. 11, 2016 Laboratory glassware ... in laboratories. These may range from microscope slides to ... is made from borosilicate glass because of its low ... the other hand, started gaining popularity over the past ... to replace glass with plastic in several applications due ...
(Date:2/11/2016)... 2016 Potrero Medical, Inc., the developer of the ... appointment of George M. Rapier, III , MD, to ... , WellMed is one of the nation,s largest physician ... members in Texas and ... his own internal medicine practice, he has been instrumental to ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... February 13, 2016 , ... Valentine’s Day is nearly upon us, ... big day. A great outfit, flawless hair, and a sparkling personality are all well ... themselves to a night at home with Rover. (Actually, man’s best friend might not ...
(Date:2/13/2016)... ... ... individuals looking to lead a healthy lifestyle have decreased carbohydrate consumption and increased their ... delved into this niche allowing those giving up their beloved pasta a chance to ... of protein and only 7 grams of carbohydrates per 50 gram serving--a ratio that ...
(Date:2/13/2016)... ... February 13, 2016 , ... The producers of Enterprises TV ... , The increasingly modern world of instantaneous consumption proves very convenient for businesses. ... such as oil and coal, which pollutes our air, water, and soil. It can ...
(Date:2/13/2016)... ... 13, 2016 , ... Christie Medical Holdings, Inc. presented the ... VeinViewer® Vision vein finder for the nursing school simulation lab. This ... draw blood, combining technology with traditional technique. , “VeinViewer is a wonderful new ...
(Date:2/13/2016)... Montreal, Canada (PRWEB) , ... February 13, 2016 , ... ... best foot forward. They’ll groom themselves to perfection, go out of their way to ... their date – just take a look at any online dating profile. , ...
Breaking Medicine News(10 mins):